| Shareholder | |||||
|---|---|---|---|---|---|
Clal Life Sciences L.P. | 9.08% | 1.17M | 0.05% | +0 | |
Clal Life Sciences L.P. | 9.08% | 1.17M | 0.04% | +0 | |
HOLD Fund Management Ltd | 8.06% | 1.04M | 2.57% | +336.53K | |
HOLD Fund Management Ltd | 8.06% | 1.04M | 0.04% | +0 | |
Mölnlycke Health Care AB | 6.76% | 872.09K | 0.04% | +0 | |
Investor AB (publ) | 6.76% | 872.09K | 0.04% | +0 | |
Mölnlycke Health Care AB | 6.76% | 872.09K | 0.03% | +0 | |
Investor AB (publ) | 6.76% | 872.09K | 0.03% | +0 | |
Yelin Lapidot Holdings Ltd. | 5.87% | 758.17K | 0.06% | -4.65K | |
Yelin Lapidot Holdings Ltd. | 5.87% | 758.17K | 0.06% | -4.65K | |
Rosalind Advisors, Inc. | 5.80% | 749.05K | 0.03% | +0 | |
Rosalind Advisors, Inc. | 5.80% | 749.05K | 0.03% | +0 | |
T. Rowe Price Group, Inc. | 5.50% | 709.85K | 1.18% | +155.35K | |
T. Rowe Price Group, Inc. | 4.97% | 641.08K | 0.56% | -68.77K | |
BlackRock, Inc. | 4.07% | 525.93K | 0.60% | +80.10K | |
BlackRock, Inc. | 4.07% | 525.93K | 0.60% | +80.10K | |
Israel Biotech Fund | 2.93% | 378.62K | 0.02% | +0 | |
Israel Biotech Fund | 2.93% | 378.62K | 0.01% | +0 | |
Clal Biotechnology Industries Ltd. | 2.39% | 308.81K | 0.01% | +0 | |
Clal Biotechnology Industries Ltd. | 2.39% | 308.81K | 0.01% | +0 |
